News
At the 5,000-square-foot Roche Community Garden, Roche employees grow tomatoes, strawberries, watermelons and a variety of ...
GlobalData on MSN19d
Manufacturing issues at Novo facility disrupt Regeneron drug review
Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate regulatory delays for blockbuster ophthalmology drug Eylea HD due to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback